Aneurysm flow diverters

Pipeline™ Flex with Shield Technology™

<p>Pipeline™ Flex with Shield Technology™ is a third-generation embolization device designed&nbsp;for placement in a parent vessel across the neck of an intracranial aneurysm (IA).</p>

Features

3rd generation Pipeline™ flow diverter offers Shield Technology™

Legacy of the Pipeline™ flow diverters, this third generation of flow diverters offers an alternative solution for the treatment of aneurysms.

This device is made of 48 braids: 36 cobalt-chromium and 12 platinum wires for radiopacity.

Pipeline™ header close up image.

Surface modification

Shield TechnologyTM is a surface modification where inert synthetic phosphorylcholine (PC) polymer is covalently-chemically-bonded to the strands that make up the Pipeline™ device implant.2

 

Pipeline™ Shield Technology membrane image.

Clinical results

PFlex study

Study shows that Pipeline™ Flex with Shield Technology™ is safe and effective for the treatment of intracranial aneurysms.

  • 0% target aneurysm recurrence3
  • 0% major stroke in the territory supplied by the treated artery3

Device delivery

Delivering flow diverters

It is recommended to use a 0.027" micro catheter for the delivery of Pipeline™ Flex with Shield Technology™ flow diverters.

Phenom™ 0.027" microcatheter image

Ordering information

Item number Diameter (mm) Length (mm)
PED2-250-10 2.50 10
PED2-250-14 2.50 14
PED2-250-16 2.50 16
PED2-250-20 2.50 20
PED2-275-12 2.75 12
PED2-275-14 2.75 14
PED2-275-16 2.75 16
PED2-275-18 2.75 18
PED2-275-20 2.75 20
PED2-300-10 3.0 10
PED2-300-12 3.0 12
PED2-300-14 3.0 14
PED2-300-16 3.0 16
PED2-300-18 3.0 18
PED2-300-20 3.0 20
PED2-300-25 3.0 25
PED2-300-30 3.0 30
PED2-300-35 3.0 35
PED2-325-10 3.25 10
PED2-325-12 3.25 12
PED2-325-14 3.25 14
PED2-325-16 3.25 16
PED2-325-18 3.25 18
PED2-325-20 3.25 20
PED2-325-25 3.25 25
PED2-325-30 3.25 30
PED2-325-35 3.25 35
PED2-350-10 3.5 10
PED2-350-12 3.5 12
PED2-350-14 3.5 14
PED2-350-16 3.5 16
PED2-350-18 3.5 18
PED2-350-20 3.5 20
PED2-350-25 3.5 25
PED2-350-30 3.5 30
PED2-350-35 3.5 35
PED2-375-10 3.75 10
PED2-375-12 3.75 12
PED2-375-14 3.75 14
PED2-375-16 3.75 16
PED2-375-18 3.75 18
PED2-375-20 3.75 20
PED2-375-25 3.75 25
PED2-375-30 3.75 30
PED2-375-35 3.75 35
PED2-400-10 4.0 10
PED2-400-12 4.0 12
PED2-400-14 4.0 14
PED2-400-16 4.0 16
PED2-400-18 4.0 18
PED2-400-20 4.0 20
PED2-400-25 4.0 25
PED2-400-30 4.0 30
PED2-400-35 4.0 35
PED2-425-10 4.25 10
PED2-425-12 4.25 12
PED2-425-14 4.25 14
PED2-425-16 4.25 16
PED2-425-18 4.25 18
PED2-425-20 4.25 20
PED2-425-25 4.25 25
PED2-425-30 4.25 30
PED2-425-35 4.25 35
PED2-450-10 4.50 10
PED2-450-12 4.50 12
PED2-450-14 4.50 14
PED2-450-16 4.50 16
PED2-450-18 4.50 18
PED2-450-20 4.50 20
PED2-450-25 4.50 25
PED2-450-30 4.50 30
PED2-450-35 4.50 35
PED2-475-10 4.75 10
PED2-475-12 4.75 12
PED2-475-14 4.75 14
PED2-475-16 4.75 16
PED2-475-18 4.75 18
PED2-475-20 4.75 20
PED2-475-25 4.75 25
PED2-475-30 4.75 30
PED2-475-35 4.75 35
PED2-500-10 5.0 10
PED2-500-12 5.0 12
PED2-500-14 5.0 14
PED2-500-16 5.0 16
PED2-500-18 5.0 18
PED2-500-20 5.0 20
PED2-500-25 5.0 25
PED2-500-30 5.0 30
PED2-500-35 5.0 35

† Please note that some of these studies were conducted OUS and may not comply with the U.S indications for use. See IFU for U.S indication. Pipeline embolization device (Classic) is no longer commercially distributed.

‡ Compared to Pipeline™ Flex embolization device. Data derived from reference bench testing may not be representative of clinical performance.

  1. Elarjani T, Almutairi OT, Bafaquh M, Alturki AY. Bibliometric Analysis of the Top 100 Most-Cited Articles on Intracranial Flow Diversion. World Neurosurg. 2021 Feb;146:e618-e630. doi: 10.1016/j.wneu.2020.10.150. Epub 2020 Nov 2. PMID: 33152498.
  2. Girdhar G, Li J, Kostousov L, Wainwright J, Chandler WL. In-vitro thrombogenicity assessment of flow diversion and aneurysm bridging devices. J Thromb Thrombolysis. 2015 Nov;40(4):437-43. doi: 10.1007/s11239-015-1228-0. PMID: 25975924.
  3. Martínez-Galdámez M, Lamin SM, Lagios KG, Liebig T, et al. Treatment of intracranial aneurysms using the pipeline flex embolization device with shield technology: angiographic and safety outcomes at 1-year follow-up. J Neurointerv Surg. 2019;11(4):396–399. doi: 10.1136/neurintsurg-2018-014204. Epub. 2018.